Product Program year 2025 Source: CMS Open Payments

ORBERA Intragastric Balloon System

Device ORBERA Intragastric Balloon System_ENDO

PDI 10811955020619

Open in the dashboard

General payments

$375,288

255 payments

Research payments

$0

0 payments

Through program year 2025, $375,288 in general payments and $0 in research payments were reported against ORBERA Intragastric Balloon System (ORBERA Intragastric Balloon System_ENDO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $293,813 159
2024 General $81,346 95
2023 General $129 1

Breakdown

Who paid General payments · program years 2023–2025
  1. Boston Scientific Corporation $375,288 255 payments
Top recipients General payments · program year 2025
  1. Natan Zundel Surgery · North Miami Beach, FL $49,725 17% · 5 payments
  2. Christopher Chapman Gastroenterology · Chicago, IL $47,530 16% · 20 payments
  3. Robert Snow Surgery · Fort Worth, TX $28,000 10% · 8 payments
  4. Margaret Keane Gastroenterology · Baltimore, MD $24,142 8% · 11 payments
  5. Halim Charbel Gastroenterology · Germantown, MD $22,817 8% · 10 payments

The top 5 of 51 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $151,053 55% · 25 practitioners
  2. Surgery $115,117 42% · 9 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $5,244 2% · 4 practitioners
  4. Internal Medicine $528 <1% · 5 practitioners
  5. Physician Assistant $334 <1% · 2 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Illinois $67,102 23% · 9 recipients
  2. Florida $59,137 20% · 2 recipients
  3. Maryland $46,959 16% · 2 recipients
  4. New York $33,102 11% · 7 recipients
  5. Texas $28,579 10% · 5 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

255 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record